Cargando…

Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period

BACKGROUND: A low proportion of P. vivax-exposed individuals acquire protective strain-transcending neutralizing IgG antibodies that are able to block the interaction between the Duffy binding protein II (DBPII) and its erythrocyte-specific invasion receptor. In a recent study, a novel surface-engin...

Descripción completa

Detalles Bibliográficos
Autores principales: Medeiros, Camila M. P., Moreira, Eduardo U. M., Pires, Camilla V., Torres, Letícia M., Guimarães, Luiz F. F., Alves, Jéssica R. S., Lima, Bárbara A. S., Fontes, Cor J. F., Costa, Helena L., Brito, Cristiana F. A., Sousa, Tais N., Ntumngia, Francis B., Adams, John H., Kano, Flora S., Carvalho, Luzia H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205269/
https://www.ncbi.nlm.nih.gov/pubmed/32379804
http://dx.doi.org/10.1371/journal.pone.0232786
_version_ 1783530210410364928
author Medeiros, Camila M. P.
Moreira, Eduardo U. M.
Pires, Camilla V.
Torres, Letícia M.
Guimarães, Luiz F. F.
Alves, Jéssica R. S.
Lima, Bárbara A. S.
Fontes, Cor J. F.
Costa, Helena L.
Brito, Cristiana F. A.
Sousa, Tais N.
Ntumngia, Francis B.
Adams, John H.
Kano, Flora S.
Carvalho, Luzia H.
author_facet Medeiros, Camila M. P.
Moreira, Eduardo U. M.
Pires, Camilla V.
Torres, Letícia M.
Guimarães, Luiz F. F.
Alves, Jéssica R. S.
Lima, Bárbara A. S.
Fontes, Cor J. F.
Costa, Helena L.
Brito, Cristiana F. A.
Sousa, Tais N.
Ntumngia, Francis B.
Adams, John H.
Kano, Flora S.
Carvalho, Luzia H.
author_sort Medeiros, Camila M. P.
collection PubMed
description BACKGROUND: A low proportion of P. vivax-exposed individuals acquire protective strain-transcending neutralizing IgG antibodies that are able to block the interaction between the Duffy binding protein II (DBPII) and its erythrocyte-specific invasion receptor. In a recent study, a novel surface-engineered DBPII-based vaccine termed DEKnull-2, whose antibody response target conserved DBPII epitopes, was able to induce broadly binding-inhibitory IgG antibodies (BIAbs) that inhibit P. vivax reticulocyte invasion. Toward the development of DEKnull-2 as an effective P. vivax blood-stage vaccine, we investigate the relationship between naturally acquired DBPII-specific IgM response and the profile of IgG antibodies/BIAbs activity over time. METHODOLOGY/PRINCIPAL FINDINGS: A nine-year follow-up study was carried-out among long-term P. vivax-exposed Amazonian individuals and included six cross-sectional surveys at periods of high and low malaria transmission. DBPII immune responses associated with either strain-specific (Sal1, natural DBPII variant circulating in the study area) or conserved epitopes (DEKnull-2) were monitored by conventional serology (ELISA-detected IgM and IgG antibodies), with IgG BIAbs activity evaluated by functional assays (in vitro inhibition of DBPII–erythrocyte binding). The results showed a tendency of IgM antibodies toward Sal1-specific response; the profile of Sal1 over DEKnull-2 was not associated with acute malaria and sustained throughout the observation period. The low malaria incidence in two consecutive years allowed us to demonstrate that variant-specific IgG (but not IgM) antibodies waned over time, which resulted in IgG skewed to the DEKnull-2 response. A persistent DBPII-specific IgM response was not associated with the presence (or absence) of broadly neutralizing IgG antibody response. CONCLUSIONS/SIGNIFICANCE: The current study demonstrates that long-term exposure to low and unstable levels of P. vivax transmission led to a sustained DBPII-specific IgM response against variant-specific epitopes, while sustained IgG responses are skewed to conserved epitopes. Further studies should investigate on the role of a stable and persistent IgM antibody response in the immune response mediated by DBPII.
format Online
Article
Text
id pubmed-7205269
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72052692020-05-12 Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period Medeiros, Camila M. P. Moreira, Eduardo U. M. Pires, Camilla V. Torres, Letícia M. Guimarães, Luiz F. F. Alves, Jéssica R. S. Lima, Bárbara A. S. Fontes, Cor J. F. Costa, Helena L. Brito, Cristiana F. A. Sousa, Tais N. Ntumngia, Francis B. Adams, John H. Kano, Flora S. Carvalho, Luzia H. PLoS One Research Article BACKGROUND: A low proportion of P. vivax-exposed individuals acquire protective strain-transcending neutralizing IgG antibodies that are able to block the interaction between the Duffy binding protein II (DBPII) and its erythrocyte-specific invasion receptor. In a recent study, a novel surface-engineered DBPII-based vaccine termed DEKnull-2, whose antibody response target conserved DBPII epitopes, was able to induce broadly binding-inhibitory IgG antibodies (BIAbs) that inhibit P. vivax reticulocyte invasion. Toward the development of DEKnull-2 as an effective P. vivax blood-stage vaccine, we investigate the relationship between naturally acquired DBPII-specific IgM response and the profile of IgG antibodies/BIAbs activity over time. METHODOLOGY/PRINCIPAL FINDINGS: A nine-year follow-up study was carried-out among long-term P. vivax-exposed Amazonian individuals and included six cross-sectional surveys at periods of high and low malaria transmission. DBPII immune responses associated with either strain-specific (Sal1, natural DBPII variant circulating in the study area) or conserved epitopes (DEKnull-2) were monitored by conventional serology (ELISA-detected IgM and IgG antibodies), with IgG BIAbs activity evaluated by functional assays (in vitro inhibition of DBPII–erythrocyte binding). The results showed a tendency of IgM antibodies toward Sal1-specific response; the profile of Sal1 over DEKnull-2 was not associated with acute malaria and sustained throughout the observation period. The low malaria incidence in two consecutive years allowed us to demonstrate that variant-specific IgG (but not IgM) antibodies waned over time, which resulted in IgG skewed to the DEKnull-2 response. A persistent DBPII-specific IgM response was not associated with the presence (or absence) of broadly neutralizing IgG antibody response. CONCLUSIONS/SIGNIFICANCE: The current study demonstrates that long-term exposure to low and unstable levels of P. vivax transmission led to a sustained DBPII-specific IgM response against variant-specific epitopes, while sustained IgG responses are skewed to conserved epitopes. Further studies should investigate on the role of a stable and persistent IgM antibody response in the immune response mediated by DBPII. Public Library of Science 2020-05-07 /pmc/articles/PMC7205269/ /pubmed/32379804 http://dx.doi.org/10.1371/journal.pone.0232786 Text en © 2020 Medeiros et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Medeiros, Camila M. P.
Moreira, Eduardo U. M.
Pires, Camilla V.
Torres, Letícia M.
Guimarães, Luiz F. F.
Alves, Jéssica R. S.
Lima, Bárbara A. S.
Fontes, Cor J. F.
Costa, Helena L.
Brito, Cristiana F. A.
Sousa, Tais N.
Ntumngia, Francis B.
Adams, John H.
Kano, Flora S.
Carvalho, Luzia H.
Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
title Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
title_full Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
title_fullStr Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
title_full_unstemmed Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
title_short Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
title_sort dynamics of igm and igg responses to the next generation of engineered duffy binding protein ii immunogen: strain-specific and strain-transcending immune responses over a nine-year period
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205269/
https://www.ncbi.nlm.nih.gov/pubmed/32379804
http://dx.doi.org/10.1371/journal.pone.0232786
work_keys_str_mv AT medeiroscamilamp dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT moreiraeduardoum dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT pirescamillav dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT torresleticiam dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT guimaraesluizff dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT alvesjessicars dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT limabarbaraas dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT fontescorjf dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT costahelenal dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT britocristianafa dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT sousataisn dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT ntumngiafrancisb dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT adamsjohnh dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT kanofloras dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod
AT carvalholuziah dynamicsofigmandiggresponsestothenextgenerationofengineeredduffybindingproteiniiimmunogenstrainspecificandstraintranscendingimmuneresponsesoveranineyearperiod